Skip to main content
Terug
NWKHY logo

Netcare Limited

Datakwaliteit: 100%
Overbought
NWKHY
OTC Healthcare Medical - Care Facilities
€ 7,17
€ 0,00 (0,00%)
Marktkapitalisatie: 854,53M
Dagbereik
€ 7,17 € 7,17
52-Weeksbereik
€ 7,17 € 8,66
Volume
1
50D / 200D Gem.
€ 7,17 / € 7,40
Vorige Slotkoers
€ 7,17

Koershistorie

Financiële Trends

Sectorvergelijking

vs Healthcare sector mediaan (626 peers)

Metriek Aandeel Sector Mediaan
P/E 0,5 0,4
P/B 0,1 2,9
ROE % 16,0 3,7
Net Margin % 6,6 3,8
Rev Growth 5Y % 5,6 10,0
D/E 1,2 0,2

Belangrijkste Punten

Revenue grew 5,58% annually over 5 years — modest growth
Earnings grew 16,28% over the past year
ROE of 15,99% — decent returns on equity
Generating 122,15M in free cash flow
P/E of 0,49 — trading at a low valuation
PEG of 0,52 suggests growth is underpriced

Groei

Revenue Growth (5Y)
5,58%
Revenue (1Y)4,53%
Earnings (1Y)16,28%
FCF Growth (3Y)-68,68%

Kwaliteit

Return on Equity
15,99%
ROIC8,52%
Net Margin6,62%
Op. Margin10,28%

Veiligheid

Debt / Equity
1,19
Current Ratio1,15
Interest Coverage42,22

Waardering

P/E Ratio
0,49
P/B Ratio0,08
EV/EBITDA4,40
Dividend Yield0,00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 4,53% Revenue Growth (3Y) 5,43%
Earnings Growth (1Y) 16,28% Earnings Growth (3Y) 17,76%
Revenue Growth (5Y) 5,58% Earnings Growth (5Y) 22,70%
Profitability
Revenue (TTM) 26,34B Net Income (TTM) 1,74B
ROE 15,99% ROA 5,96%
Gross Margin 49,70% Operating Margin 10,28%
Net Margin 6,62% Free Cash Flow (TTM) 122,15M
ROIC 8,52% FCF Growth (3Y) -68,68%
Safety
Debt / Equity 1,19 Current Ratio 1,15
Interest Coverage 42,22 Dividend Yield 0,00%
Valuation
P/E Ratio 0,49 P/B Ratio 0,08
P/S Ratio 0,03 PEG Ratio 0,52
EV/EBITDA 4,40 Dividend Yield 0,00%
Market Cap 854,53M Enterprise Value 11,93B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 26,34B 25,20B 23,70B 21,64B 21,20B
Net Income 1,74B 1,50B 1,26B 1,01B 769,00M
EPS (Diluted) 12,70 10,88 9,40 7,20 5,40
Gross Profit 13,09B 12,46B 11,76B 10,55B 10,45B
Operating Income 2,71B 3,16B 2,72B 2,46B 2,08B

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 29,23B 28,39B 27,80B 26,27B 25,62B
Total Liabilities 18,24B 17,42B 16,76B 15,33B 15,03B
Shareholders' Equity 10,87B 10,93B 11,02B 10,89B 10,58B
Total Debt 12,97B 12,65B 12,30B 10,86B 10,88B
Cash & Equivalents 1,89B 1,80B 2,28B 1,50B 1,46B
Current Assets 6,51B 6,38B 6,43B 5,44B 5,60B
Current Liabilities 5,65B 6,26B 5,60B 5,28B 5,62B

Strategiescores

This stock passed the criteria for 1 strategy

Score = fit strength (0–100)
Rank = position among all matches
Custom Contrarian Investing (David Dreman)
#596 of 658
5

Recente Activiteit

Ingestapt Contrarian Investing (David Dreman)
Mar 24, 2026